Lundbeck expresses interest in buying Xeris, Bloomberg News reports
Danish drugmaker H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma NASDAQ:XERS, Bloomberg News reported on Tuesday, citing people familiar with the matter.
Danish drugmaker H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma NASDAQ:XERS, Bloomberg News reported on Tuesday, citing people familiar with the matter.